https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MS.jpg

Vascular Access Devices Market Size, Share & Trends Analysis | Europe | 2020-2026 | MedSuite | Includes: Implantable Port Market, Port Needle Market, Central Venous Catheter Market, and 10 more

  • Year: 2020
  • Scope: 10 Years
  • Region: Europe
  • Pages: 934
  • Published Date: 05/11/2020
  • Type: MedSuite

In 2020, the European vascular access devices market size was valued at €1.7 billion, with around 130 million vascular access devices placed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 1.7% to reach €1.9 billion in 2026.

Throughout this medical market research, we analyzed 63 vascular access companies across Europe and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all the EU Vascular Access Devices market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Vascular Access Procedure Volumes
  • Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each Vascular Access Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Market Value and Industry Trends

Market growth is expected to be limited by pricing pressures across Europe. European healthcare facilities often trend towards lower-cost products, which forces many competitors to lower their prices. Furthermore, preferences for high cost, premium-priced versions of products, such as those with antimicrobial coatings, is still developing in many markets. As such, premiums on many of these devices are still being kept low and, therefore, there is not a significant upward force on the market from conversion to these products.

EU Vascular Access Devices Market Size by Segment, 2016-2026

On the other hand, the market is benefitting from increased conversion towards safety devices that prevent needle-stick injuries. This trend is having a particularly strong effect in the PIVC and syringe and needle markets, which represent a sizable portion of the total vascular access market in Europe. Europe-wide legislation encouraging the use of safety devices implemented in 2013 and early 2014 has been transposed in all countries included in this report.

Long-term devices, such as implantable ports, CVCs, and PICCs, are expected to be among the fastest-growing segments of the global vascular access device market. Long-term catheters are typically much more expensive than short-term devices, like PIVCs. Furthermore, there is a high degree of motivation for technological improvement in those spaces. Power-injection is a growing trend for implantable ports and PICCs, allowing for high-pressure injections, such as those required for CT scans.

Competitive Analysis

Leading Competitors in the EU Vascular Access Market

By 2020, Becton Dickinson led the European vascular access device and accessories market. Since its 2017 acquisition of C.R. Bard, Becton Dickinson has continued to be a major player in both traditional vascular access devices and accessories. With the acquisition of C.R. Bard, the company
now leads the majority of market segments covered in this report, and is the second or third leading competitor in most of the remaining markets.

B. Braun was the second-most-prominent competitor in the European vascular access market by 2020. The company managed this by being the second-leading competitor in a large host of markets, including implantable ports, port needles, CVCs, PIVCs and syringes and needles.

3M, despite only being present in the catheter securement market, was the third-largest player in the total vascular access device and accessories market. 3M derives its large revenue share from its high-volume sales of catheter dressings and securement devices, which are used with the majority of catheters placed in Europe.

REPORT REGIONAL COVERAGE

Throughout this research series, iData Research has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The countries covered are:

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Switzerland
  • Austria
  • Portugal

Segments Covered

Feel free to click on any of the segments below to view detailed market segmentation.

Detailed Market Segmentation


DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report

TABLE OF CONTENTS I

LIST OF FIGURES XIIILIST OF CHARTS XLIEXECUTIVE SUMMARY 1

EUROPEAN VASCULAR ACCESS DEVICES AND ACCESSORIES MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4MARKET TRENDS 7MARKET DEVELOPMENTS 9PROCEDURE NUMBERS 10MARKETS INCLUDED 11KEY REPORT UPDATES 14VERSION HISTORY 15RESEARCH METHODOLOGY 16Step 1: Project Initiation & Team Selection 16Step 2: Prepare Data Systems and Perform Secondary Research 19Step 3: Preparation for Interviews & Questionnaire Design 21Step 4: Performing Primary Research 22Step 5: Research Analysis: Establishing Baseline Estimates 24Step 6: Market Forecast and Analysis 25Step 7: Identify Strategic Opportunities 27Step 8: Final Review and Market Release 28Step 9: Customer Feedback and Market Monitoring 29

DISEASE OVERVIEW 30

2.1 BASIC ANATOMY 302.1.1 Human Vascular System 302.2 DISEASE TREATMENTS & DIAGNOSTICS 312.2.1 Cancer 312.2.2 End-Stage Renal Disease 322.2.3 Diabetes 342.3 PATIENT DEMOGRAPHICS 372.3.1 Cancer 372.3.1.1 Breast Cancer 372.3.1.2 Colon and Rectum 382.3.1.3 Kidney and Renal Pelvis 392.3.1.4 Leukemia 392.3.1.5 Liver 402.3.1.6 Lungs and Bronchus 402.3.1.7 Lymphoma 412.3.1.8 Oral Cavity and Pharynx 412.3.1.9 Ovary 422.3.1.10 Pancreas 422.3.1.11 Prostate 432.3.1.12 Skin 432.3.2 End-Stage Renal Disease 432.3.3 Diabetes 44

PRODUCT ASSESSMENT 47

3.1 INTRODUCTION 473.2 PRODUCT PORTFOLIOS 473.2.1 Port Needles 473.2.1.1 Introduction 473.2.1.2 Product Portfolio 483.2.2 Implantable Ports 493.2.2.1 Introduction 493.2.2.1.1 Implantable Port Patients 493.2.2.1.2 Port Implantation Procedures 493.2.2.1.3 Port Infusion 503.2.2.1.4 Port Maintenance 503.2.2.2 Product Portfolio 513.2.3 Central Venous Catheters (CVCs) 523.2.3.1 Introduction 523.2.3.1.1 CVC Procedures 523.2.3.1.2 CVC Kits 533.2.3.1.3 CVC Market Segments 533.2.3.2 Product Portfolio 563.2.4 Peripherally Inserted Venous Catheters (PIVCs) 583.2.4.1 Introduction 583.2.4.2 Product Portfolio 593.2.5 Peripherally Inserted Central Catheters (PICCs) 613.2.5.1 Introduction 613.2.5.2 PICC Placement 613.2.5.3 Product Portfolio 623.2.6 Midlines 643.2.6.1 Product Portfolio 643.2.7 Dialysis Catheters 653.2.7.1 Introduction 653.2.7.1.1 AV Fistulae 653.2.7.1.2 AV Grafts 663.2.7.1.3 Dialysis Catheters 663.2.7.2 Product Portfolio 693.2.8 Syringes and Needles 713.2.8.1 Introduction 713.2.8.2 Product Portfolio 733.2.9 Catheter Securement 763.2.9.1 Introduction 763.2.9.1.1 Catheter Stabilization Methods 763.2.9.2 Product Portfolio 793.2.10 Tip-Placement System and Accessories 813.2.10.1 Introduction 813.2.10.2 Product Portfolio 823.2.11 Ultrasound Vascular Access Devices and Accessories 833.2.11.1 Introduction 833.2.11.1.1 Alternates to Ultrasound Guidance 833.2.11.1.2 Ultrasound Guidance 843.2.11.1.3 Ultrasound Vessel Mapping 853.2.11.1.4 General Ultrasound Imaging Systems with Vascular Access Guidance Capabilities Market 853.2.11.2 Product Portfolio 863.2.12 Vein Visualization Technology 893.2.12.1 Product Portfolio 893.3 FDA RECALLS 903.3.1 Port Needles 903.3.2 Implantable Ports 903.3.3 Central Venous Catheters (CVCs) 913.3.4 Peripherally Inserted Central Catheters (PICCs) 933.4 CLINICAL TRIALS 943.4.1 Vascular Access Devices 94

EUROPEAN VASCULAR ACCESS DEVICES AND ACCESSORIES MARKET OVERVIEW 100

4.1 INTRODUCTION 1004.2 CURRENCY EXCHANGE RATE 1014.3 MARKET OVERVIEW 1024.4 TREND ANALYSIS BY SEGMENT 1104.5 DRIVERS AND LIMITERS 1154.5.1 Market Drivers 1154.5.2 Market Limiters 1164.6 COMPETITIVE MARKET SHARE ANALYSIS 1194.7 MERGERS AND ACQUISITIONS 1274.8 COMPANY PROFILES 1304.8.1 3M 1304.8.2 AngioDynamics 1314.8.3 B. Braun 1324.8.4 Becton Dickinson 1334.8.5 Cook Medical 1354.8.6 FUJIFILM SonoSite 1364.8.7 GE Healthcare 1374.8.8 Medcomp 1384.8.9 Medtronic 1394.8.10 Novo Nordisk 1404.8.11 Smiths Medical 1414.8.12 Siemens 1424.8.13 Teleflex Medical 1434.9 SWOT ANALYSIS 1454.9.1 3M 1454.9.2 AngioDynamics 1464.9.4 B. Braun 1474.9.5 Becton Dickinson 1484.9.6 Cook Medical 1494.9.7 FUJIFILM SonoSite 1504.9.8 GE Healthcare 1514.9.9 Medcomp 1524.9.10 Medtronic 1534.9.11 Novo Nordisk 1544.9.12 Smiths Medical 1554.9.13 Siemens 1564.9.14 Teleflex Medical 157

COUNTRY PROFILES 158

5.1 INTRODUCTION 1585.1.1 Population 1585.1.2 GDP Per Capita 1585.1.3 Price Index 1585.2 GERMANY 1595.3 FRANCE 1605.4 UNITED KINGDOM 1615.5 ITALY 1625.6 SPAIN 1635.7 BENELUX 1645.8 SCANDINAVIA 1655.9 AUSTRIA 1665.10 SWITZERLAND 1675.11 PORTUGAL 168

PROCEDURE NUMBERS 169

6.1 PROCEDURES 1696.1.1 Total Vascular Access Procedures 1696.1.2 Implantable Port Procedures 1736.1.3 Port Needle Procedures 1766.1.4 CVC Procedures 1796.1.5 PICC Procedures 1826.1.6 PIVC Procedures 1856.1.7 Midline Procedures 1886.1.8 Dialysis Catheter Procedures 191

IMPLANTABLE PORT MARKET 197

7.1 INTRODUCTION 1977.2 MARKET OVERVIEW 1987.3 MARKET ANALYSIS AND FORECAST 2037.3.1 Total Implantable Port Market 2037.3.2 Total Non-Power-Injectable Implantable Port Market 2117.3.2.1 Single-Lumen Non-Power-Injectable Implantable Port Market 2227.3.2.2 Double-Lumen Non-Power-Injectable Implantable Port Market 2297.3.3 Total Power-Injectable Implantable Port Market 2367.3.3.1 Single-Lumen Power-Injectable Implantable Port Market 2477.3.3.2 Double-Lumen Power-Injectable Implantable Port Market 2547.4 DRIVERS AND LIMITERS 2617.4.1 Market Drivers 2617.4.2 Market Limiters 2627.5 COMPETITIVE MARKET SHARE ANALYSIS 265

PORT NEEDLE MARKET 270

8.1 INTRODUCTION 2708.2 MARKET OVERVIEW 2718.3 MARKET ANALYSIS AND FORECAST 2778.3.1 Total Port Needle Market 2778.3.2 Conventional Port Needle Market 2858.3.3 Total Safety Port Needle Market 2938.3.3.1 Power-Injectable Safety Port Needle Market 3048.3.3.2 Non-Power-Injectable Safety Port Needle Market 3128.4 DRIVERS AND LIMITERS 3198.4.1 Market Drivers 3198.4.2 Market Limiters 3208.5 COMPETITIVE MARKET SHARE ANALYSIS 321

CENTRAL VENOUS CATHETER MARKET 326

9.1 INTRODUCTION 3269.2 UNIT ANALYSIS 3279.2.1.1 Acute CVC Units Sold by Patient Type 3279.3 MARKET OVERVIEW 3289.4 MARKET ANALYSIS AND FORECAST 3349.4.1 Total Central Venous Catheter Market 3349.4.2 Total Acute Central Venous Catheter Market 3429.4.2.1 Total Acute Central Venous Catheter Market by Device Type 342Conventional Acute Central Venous Catheter Market 353Antimicrobial Acute Central Venous Catheter Market 3619.4.2.2 Total Acute Central Venous Catheter Market by Power-Injectability 369Power-Injectable Acute Central Venous Catheter Market 375Non-Power-Injectable Acute Central Venous Catheter Market 3789.4.3 Chronic Central Venous Catheter Market 380Power-Injectable Chronic Central Venous Catheter Market 391Non-Power-Injectable Chronic Central Venous Catheter Market 3939.5 DRIVERS AND LIMITERS 3959.5.1 Market Drivers 3959.5.2 Market Limiters 3969.6 COMPETITIVE MARKET SHARE ANALYSIS 398

PERIPHERALLY INSERTED CENTRAL CATHETER MARKET 406

10.1 INTRODUCTION 40610.2 MARKET OVERVIEW 40710.2.1 Total Peripherally Inserted Central Catheter Market by Lumen Number 40710.2.2 Total Peripherally Inserted Central Catheter Market by Power-Injectability 41210.2.3 Total Peripherally Inserted Central Catheter Market by Tip-Placement Type 41810.3 MARKET ANALYSIS AND FORECAST 42310.3.1 Total Peripherally Inserted Central Catheter Market 42310.3.2 Total Peripherally Inserted Central Catheter Market by Lumen Number 43110.3.2.1 Single-Lumen Peripherally Inserted Central Catheter Market 43110.3.2.2 Double-Lumen Peripherally Inserted Central Catheter Market 43910.3.2.3 Triple-Lumen Peripherally Inserted Central Catheter Market 44610.3.3 Total Peripherally Inserted Central Catheter Market by Power-Injectability 45310.3.3.1 Non-Power-Injectable Peripherally Inserted Central Catheter Market 45310.3.3.2 Total Power-Injectable Peripherally Inserted Central Catheter Market 46110.3.3.2.1 Advanced Materials Power-Injectable Peripherally Inserted Central Catheter Market 47210.3.3.2.2 Conventional Power-Injectable Peripherally Inserted Central Catheter Market 47910.3.4 Total Peripherally Inserted Central Catheter Market by Tip-Placement Type 48610.3.4.1 Tip-Placement Peripherally Inserted Central Catheter Kit Market 48610.3.4.2 Basic Peripherally Inserted Central Catheter Kit Market 49310.4 DRIVERS AND LIMITERS 50010.4.1 Market Drivers 50010.4.2 Market Limiters 50110.5 COMPETITIVE MARKET SHARE ANALYSIS 503

PERIPHERAL INTRAVENOUS CATHETER MARKET 508

11.1 INTRODUCTION 50811.2 MARKET OVERVIEW 51011.3 MARKET ANALYSIS AND FORECAST 51611.3.1 Total Peripheral Intravenous Catheter Market 51611.3.2 Conventional Peripheral Intravenous Catheter Market 52411.3.3 Total Safety Peripheral Intravenous Catheter Market 53211.3.3.1 Blood Control Safety Peripheral Intravenous Catheter Market 54311.3.3.2 Total Non-Blood Control Safety Peripheral Intravenous Catheter Market by Segment 55111.3.3.2.1 Active Non-Blood Contro Safetyl Peripheral Intravenous Catheter Market 56211.3.3.2.2 Passive Non-Blood Control Safety Peripheral Intravenous Catheter Market 56911.4 DRIVERS AND LIMITERS 57611.4.1 Market Drivers 576 For a Full Table of Contents, please contact iData.
The Vascular Access Devices Market Report Suite | Europe | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:
  • 3M
  • Access Scientific
  • AngioDynamics
  • Applied Medical Technology
  • Argon Medical
  • Artsana
  • B. Braun
  • Baxter International
  • Becton Dickinson
  • Bionic
  • C. R. Bard
  • Cardinal Health
  • Centurion Medical
  • Codan
  • Cook Medical
  • Covidien
  • Deltamed
  • DeRoyal
  • Districlass Medical
  • Edwards Lifesciences
  • Fannin
  • Fresenius
  • GlucoRx
  • Greiner Bio-One
  • HEKA Healthcare
  • Interrad Medical
  • Investindustrial
  • Johnson & Johnson
  • Joline
  • Kimal
  • M.C. Johnson
  • Medcomp
  • Medikit
  • Medline Industries
  • Medtronic
  • Neo Medical
  • Nipro Medical
  • Nostix, LLC
  • Nova Medical
  • Novico
  • Novo Nordisk
  • Owen Mumford
  • Pentaferte
  • PFM Medical
  • Rays
  • Roche
  • Romedex
  • Safety Syringes Inc.
  • Sentra Medical
  • SFM
  • Smiths Medical
  • Smith & Nephew
  • Sonosite, Inc.
  • Teleflex
  • Terumo
  • TIDI Products
  • Troge
  • Vascular Pathways, Inc.
  • VigMed
  • V-Tech
  • Vygon
  • Ypsomed

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology